We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBT icon
726
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$15.7M 0.02%
119,248
+8,326
+8% +$1.17M
SPLK
727
DELISTED
Splunk Inc
SPLK
$15.7M 0.02%
208,780
-36,224
-15% -$3.55M
BNY
728
Bank of New York Mellon
BNY
$109B
$15.7M 0.02%
407,556
+11,629
+3% +$496K
DLTR icon
729
Dollar Tree
DLTR
$24.6B
$15.7M 0.02%
115,252
-7,597
-6% -$1.18M
ARES icon
730
Ares Management
ARES
$32.3B
$15.7M 0.02%
253,079
+12,213
+5% +$854K
UTF icon
731
Cohen & Steers Infrastructure Fund
UTF
$3.02B
$15.6M 0.02%
672,941
+102,598
+18% +$2.7M
FHN icon
732
First Horizon
FHN
$12B
$15.6M 0.02%
682,215
+38,472
+6% +$874K
FE icon
733
FirstEnergy
FE
$27.1B
$15.5M 0.02%
418,644
+109,012
+35% +$4.31M
IBDN
734
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$15.5M 0.02%
618,700
+115,442
+23% +$2.89M
EXC icon
735
Exelon
EXC
$46.2B
$15.5M 0.02%
412,828
+67,762
+20% +$3M
TSN icon
736
Tyson Foods
TSN
$19.9B
$15.5M 0.02%
234,383
-89,114
-28% -$7.05M
FTXN icon
737
First Trust Nasdaq Oil & Gas ETF
FTXN
$163M
$15.4M 0.02%
629,222
-55,616
-8% -$1.41M
SCHP icon
738
Schwab US TIPS ETF
SCHP
$16.2B
$15.4M 0.02%
595,722
-44,016
-7% -$1.22M
TRN icon
739
Trinity Industries
TRN
$2.29B
$15.4M 0.02%
720,894
+13,978
+2% +$342K
LUMN icon
740
Lumen
LUMN
$6.58B
$15.3M 0.02%
2,098,482
+19,627
+0.9% +$200K
MTN icon
741
Vail Resorts
MTN
$5.26B
$15.2M 0.02%
70,410
+4,433
+7% +$1.01M
MGC icon
742
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
$15.2M 0.02%
121,564
-4,193
-3% -$582K
TRGP icon
743
Targa Resources
TRGP
$56.9B
$15.2M 0.02%
251,322
-49,627
-16% -$3.26M
RQI icon
744
Cohen & Steers Quality Income Realty Fund
RQI
$1.66B
$15.2M 0.02%
1,346,774
-74,756
-5% -$1.07M
ICUI icon
745
ICU Medical
ICUI
$4.55B
$15.1M 0.02%
100,181
+23,679
+31% +$3.94M
PRI icon
746
Primerica
PRI
$9.63B
$15M 0.02%
121,254
+111,277
+1,115% +$14.1M
MTCH icon
747
Match Group
MTCH
$8.45B
$15M 0.02%
313,317
-40,431
-11% -$2.54M
XEL icon
748
Xcel Energy
XEL
$48.5B
$14.8M 0.02%
231,468
+4,131
+2% +$301K
FYX icon
749
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.41B
$14.7M 0.01%
201,747
+17,578
+10% +$1.43M
WBS icon
750
Webster Financial
WBS
$12.8B
$14.7M 0.01%
324,128
+54,253
+20% +$2.51M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.